NCT01344837: Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer |
|
|
| Not yet recruiting | N/A | 360 | US | Diagnostic Laboratory Biomarker Analysis, Immunohistochemistry Staining Method, Cell/Tissue, Immunohistochemistry, IHC, Immunohistochemistry, Medical Chart Review, Chart Review, Microarray Analysis, gene expression profile, Gene Expression Profiling, Microarray Technology, Microarray-Based Analysis, Study of Socioeconomic and Demographic Variables, Western Blotting, Blotting, Western, WESTERN BLOT | Gynecologic Oncology Group, National Cancer Institute (NCI) | Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer | 01/00 | | | |